Montreal, February 20, 2018 (GLOBE NEWSWIRE) – On February 14th TearLab issued a press release indicating it will appeal after its defeat in a patent infringement action against I-MED Pharma Inc. in Canada. In the press release, it was stated…
I-MED PHARMA Inc., Your Leader in Ocular Surface Disorder Management, is proud to announce the launch of our new and improved website www.imedpharma.com. This site contains a comprehensive list of all our OSD, diagnostic and surgical product offerings detailing their…
Montreal, February 13, 2018 (GLOBE NEWSWIRE) – I-MED Pharma Inc., announced today that TearLab’s efforts to keep the I-PEN® Osmolarity System off the market proved unsuccessful. I-MED Pharma wins patent case against TearLab, with costs awarded to I-MED. In February…
Copyright © 2018 I-MED Pharma inc. All rights reserved.
Privacy | Terms & Conditions
Website Design by WSI Montreal